Review Practice Exercise 3

Exam Review

Practice Exercise 3

Share This Link

Share on social media

Facebook

Messager

WhatsApp

Share URL
Copy

We are excited to announce the release of a NEW VERSION OF THE SYSTEM! To benefit from the latest features, improvements, and component updates, please switch to the new system as soon as possible.

Visit Latest Version

Total Questions : 5

Showing 5 questions, Sign in for more

Question 1:

The nurse is explaining to a student why clonidine relieves the manifestations of opioid withdrawal. Which of the following explanations by the nurse is most accurate?

A. It stimulates presynaptic alpha-2 receptors, reducing the norepinephrine surge released from the locus coeruleus. B. It occupies mu receptors with high affinity, displacing any remaining opioid from the receptor site. C. It blocks dopamine release in the nucleus accumbens, thereby eliminating craving and drug-seeking behavior. D. It restores endogenous beta-endorphin synthesis, which reverses the hyperalgesia of withdrawal.

Answer and Explanation

Choice A:

Central stimulation of presynaptic alpha-2 adrenergic autoreceptors provides negative feedback that drastically suppresses locus coeruleus firing. Suppressing this brainstem nucleus halts excessive central and peripheral norepinephrine release during acute abstinence. Blunting noradrenergic surges relieves hyperautonomic features including tachycardia, tremors, and piloerection without activating opioid receptors. Understanding adrenergic pharmacodynamics guides non-opioid withdrawal management.

Choice B:

Clonidine is an adrenergic agonist that possesses zero intrinsic affinity or binding capability for mu-opioid neuroreceptors. Displacement of receptor ligands occurs exclusively with true opioid competitive antagonists like naloxone or naltrexone. Clonidine treats autonomic hyperactivity through sympathetic blockade rather than competitive opioid receptor occupancy. Misidentifying drug classes leads to errors when anticipating opioid reversal kinetics.

Choice C:

Inhibiting dopamine transmission within the mesolimbic pathway reduces euphoric reinforcement but does not eliminate acute psychological cravings or complex drug-seeking behaviors. Clonidine primarily modulates brainstem noradrenergic circuits in the locus coeruleus rather than mesolimbic dopamine pathways. Cravings persist independently of noradrenergic stabilization and require comprehensive behavioral and medical interventions. Sympathetic suppression does not eliminate complex reward-driven cravings.

Choice D:

Endogenous peptide synthesis like beta-endorphin production remains blunted for months following chronic exogenous opioid administration. Clonidine does not accelerate neurochemical recovery or restore natural polypeptide gene transcription within pituitary or hypothalamic tissues. Reversing hyperalgesia requires gradual neuroreceptor recalibration over extended abstinence periods. Expecting rapid peptide restoration fails to reflect chronic neuroadaptation mechanisms.

Discussion Section

Posting as Anonymous or Login Here

0 Pulse Checks

No comments

Question 2:

The nurse is admitting a client whose last dose of methadone was 36 hours ago. Which of the following statements by the nurse to the oncoming shift is most accurate regarding this client's withdrawal?

A. "Symptoms peaked about 12 hours ago and should be nearly resolved by morning." B. "Symptoms will peak around 72 to 96 hours and may continue for 2 to 3 weeks." C. "Symptoms will not begin until at least 5 days after the last dose because of tissue storage." D. "Symptoms will peak within 36 to 72 hours and resolve within 5 to 10 days, as with heroin."

Answer and Explanation

Choice A:

Rapid peak and resolution within 12 to 24 hours reflect short-acting parenteral agents like fentanyl rather than long-acting methadone. Methadone withdrawal symptoms rarely manifest fully within the first 24 hours due to slow clearance from tissue storage. Expecting complete resolution by morning fails to account for methadone's extended elimination kinetics. Misjudging onset times leads to inadequate clinical surveillance.

Choice B:

Methadone's extended pharmacological half-life causes withdrawal manifestations to emerge slowly, peaking between 72 and 96 hours post-ingestion. Dissociation from tissue binding sites sustains systemic agonist exposure, extending acute physical withdrawal for 2 to 3 weeks. Informing staff of this delayed timeline ensures appropriate long-term clinical monitoring and symptom management. Accurate pharmacokinetic awareness prevents premature discontinuation of withdrawal monitoring protocols.

Choice C:

Physical withdrawal symptoms typically begin within 24 to 48 hours following the last dose, not after 5 days. Tissue storage delays initial symptom onset compared to short-acting agents, but does not forestall acute abstinence manifestations for nearly a week. Expecting no symptoms until day 5 risks missing emerging early autonomic instability. Clinical monitoring must commence immediately upon admission rather than being deferred for days.

Choice D:

Heroin exhibits a short elimination half-life, with withdrawal peaking within 36 to 72 hours and resolving in 5 to 10 days. Methadone withdrawal follows a significantly longer trajectory due to extended receptor occupancy and tissue accumulation. Conflating long-acting methadone kinetics with short-acting heroin leads to incorrect expectations regarding treatment duration. Pharmacokinetic differences dictate distinct clinical trajectories.

Discussion Section

Posting as Anonymous or Login Here

0 Pulse Checks

No comments

Question 3:

The nurse is scoring a client using the Clinical Opiate Withdrawal Scale. Which of the following are objective items the nurse rates by direct observation during this assessment? Select all that apply.

A. Pupil size assessed in room light. B. Resting pulse rate taken after the client has been seated for 1 minute. C. Gooseflesh skin noted on the client's forearms. D. The client's self-reported craving intensity on a scale of 0 to 10. E. Oxygen saturation measured by pulse oximetry.

Answer and Explanation

Choice A:

Direct visual measurement of pupillary diameter under ambient light provides an objective assessment of sympathetic autonomic arousal. Mydriasis occurs as central noradrenergic discharge overcomes parasympathetic ocular tone during acute abstinence. Measuring pupil size allows clinicians to score physical withdrawal severity without relying on client reporting. Pupil measurement serves as a validated indicator of autonomic rebound.

Choice B:

Evaluating resting heart rate following a 1-minute seated stabilization period yields a precise objective parameter of cardiovascular sympathetic surge. Locus coeruleus hyperactivity increases circulating catecholamines, producing progressive sinus tachycardia as withdrawal worsens. Standardized pulse measurement provides quantifiable physical data to guide therapeutic dosing decisions. Objective vitals assessment eliminates subjective bias during clinical scoring.

Choice C:

Observing piloerection or gooseflesh skin on exposed extremities confirms hyperautonomic cutaneous nervous system stimulation. Cold involuntary piloerection arises from sympathetic arrector pili muscle contractions characteristic of peak opioid withdrawal. Direct visual inspection of the skin provides clear physical confirmation of autonomic rebound. Visual skin inspection yields verifiable diagnostic evidence.

Choice D:

Rating subjective craving intensity on a numerical scale measures psychological desire rather than an objective physical item on the 11-item scale. Cravings represent internal psychological states that cannot be directly observed or validated by the examining nurse. The scale excludes subjective craving intensity to maintain focus on observable autonomic and physical signs. Subjective rating scales measure psychological drive rather than physical withdrawal.

Choice E:

Continuous pulse oximetry provides objective arterial oxygen saturation monitoring but is not an integrated scoring component of the standardized tool. While hypoxemia monitoring remains essential during acute overdose resuscitation, simple uncomplicated opioid withdrawal does not typically compromise peripheral oxygen saturation. Including non-standardized parameters distorts total tool scoring calculations. Oxygen saturation monitoring reflects respiratory adequacy rather than withdrawal severity.

Discussion Section

Posting as Anonymous or Login Here

0 Pulse Checks

No comments

Question 4:

The nurse is caring for a 3-day-old neonate exposed to opioids in utero who has a high-pitched cry, tremors, and poor feeding. Which of the following interventions should the nurse implement initially?

A. Swaddle the neonate in a flexed position and reduce environmental lighting and noise. B. Administer the prescribed oral morphine solution according to the scoring protocol. C. Notify the primary health care provider of the neonate's escalating abstinence scores. D. Obtain a meconium specimen to confirm the extent of intrauterine exposure.

Answer and Explanation

Choice A:

Swaddling in a flexed posture provides proprioceptive containment that decreases motor tremors and frantic hyperirritability. Dimming room lights and minimizing auditory noise reduces sensory overstimulation in a hypersensitive neonatal nervous system. Prioritizing non-pharmacological comfort interventions stabilizes hyperautonomic responses without exposing the neonate to premature medication risks. Non-pharmacological measures represent the primary initial step in managing neonatal abstinence.

Choice B:

Morphine administration is reserved for neonates whose abstinence scores remain consistently elevated despite maxed non-pharmacological comfort interventions. Initiating opiate replacement therapy without first attempting environmental modifications exposes the infant to unnecessary drug toxicity and prolonged hospitalization. Pharmacotherapy is a secondary intervention guided by protocol scoring thresholds after non-pharmacological failure. Medication administration follows initial supportive environmental comfort measures.

Choice C:

Healthcare provider notification is indicated when validated scoring tools demonstrate severe escalating withdrawal uncontrolled by non-pharmacological care. However, the immediate initial nursing action is providing direct bedside soothing to calm the distressed neonate. Provider communication occurs after implementing supportive nursing care and documenting serial abstinence scores. Environmental stabilization takes operational priority over routine provider notification.

Choice D:

Meconium collection confirms intrauterine substance exposure history but provides zero therapeutic relief for acute hyperirritability. Diagnostic specimen collection must not supersede immediate non-pharmacological comfort interventions for a distressed neonate experiencing central nervous system hyperarousal. Laboratory testing guides historical confirmation rather than acute bedside stabilization. Symptom relief precedes diagnostic sample collection.

Discussion Section

Posting as Anonymous or Login Here

0 Pulse Checks

No comments

Question 5:

The nurse is managing a client experiencing peak opioid withdrawal with profuse vomiting and diarrhea. Which of the following actions should the nurse take? Select all that apply.

A. Monitor serum potassium and administer replacement as prescribed. B. Withhold the prescribed clonidine when the systolic blood pressure is 84 mm Hg. C. Request a prescription for lorazepam to control the client's restlessness and insomnia. D. Encourage the client to take high doses of loperamide until the diarrhea fully stops. E. Reassure the client that the discomfort will resolve, as this withdrawal is uniformly fatal without sedation.

Answer and Explanation

Choice A:

Profuse fluid loss from severe gastrointestinal hypermotility excretes excessive amounts of upper and lower intestinal fluid rich in potassium. Hypokalemia precipitates dangerous cardiac dysrhythmias and severe neuromuscular weakness if left uncorrected. Serial monitoring of electrolyte panels and timely potassium replacement prevents life-threatening cardiovascular instability. Assessing electrolyte status is a vital nursing priority during acute gastrointestinal purging.

Choice B:

Clonidine is an alpha-2 adrenergic agonist that lowers central sympathetic outflow, reducing baseline arterial pressure. Administering clonidine when systolic blood pressure falls below 90 mm Hg risks triggering profound hypotension, syncope, and cerebral hypoperfusion. Withholding the dose and notifying the provider ensures patient hemodynamic safety. Nursing parameters mandate holding antihypertensives during severe hypotension.

Choice C:

Requesting routine benzodiazepines like lorazepam introduces significant risks of cross-dependence, sedation, and additive central nervous system depression. Standard non-addictive management of withdrawal-induced restlessness utilizes alpha-2 agonists, non-opioid analgesics, or sedating antihistamines rather than controlled sedatives. Introducing benzodiazepines during opioid recovery complicates addiction treatment and increases overdose vulnerability. Benzodiazepines are not first-line agents for uncomplicated opioid withdrawal restlessness.

Choice D:

High-dose loperamide administration is strongly contraindicated due to extreme cardiotoxicity, QTc prolongation, and torsades de pointes. Patients sometimes misuse excessive loperamide to achieve central opioid effects, leading to fatal cardiac arrhythmias. Diarrhea should be managed with standard therapeutic dosing of anti-diarrheals under strict medical supervision. Educating clients against megadosing prevents life-threatening cardiotoxicity.

Choice E:

Uncomplicated opioid withdrawal is extremely painful and distressing, but it is not fatal in the absence of severe uncorrected dehydration or underlying cardiovascular disease. Reassuring the client that withdrawal is inherently fatal creates unnecessary panic and spreads false medical information. Management focuses on supportive symptomatic relief, rehydration, and compassionate reassurance. Opioid withdrawal differs from alcohol or sedative withdrawal, which carries direct withdrawal-induced mortality risks.

Discussion Section

Posting as Anonymous or Login Here

0 Pulse Checks

No comments

Sign Up or Login to view all the 5 Questions on this Exam

Join over 100,000+ nursing students using Naxlex’s science-backend flashcards, practice tests and expert solutions to improve their grades and reach their goals.

Exam Review

Practice Exercise 3 Share this Share This Link Share on social media Facebook Messager WhatsApp Share URL Copy Close

Total Questions : 5

Sign Up or Login to view all the 5 Questions on this Exam

Practice Exercise 3

Share This Link

Share on social media

Facebook

Messager

WhatsApp

Share URL
Copy